The fund will be utilised for technology development and clinical validation, enabling the company to progress towards commercial production post-CDSCO licensing
Neuranics, a healthcare diagnostics startup, has successfully raised $700K in funding in a seed round led by Inflection Point Ventures (IPV). The funds will be utilised for technology development and clinical validation, enabling the company to accelerate its mission to revolutionise blood diagnostics.
Neuranics is developing a point-of-care blood analyser capable of delivering complete blood count (CBC) results in less than 10 minutes using just a finger-prick sample. The device, designed for primary and emergency settings, offers low maintenance and high efficiency, making it a game-changer for the healthcare industry.
Mitesh Shah, Co-founder, IPV, says, “Neuranics is tackling the problem of lengthy and complex blood testing processes with their point-of-care blood analyzer that makes complete blood count diagnosis faster and easier. This significantly improves patient care, especially in urgent cases. IPV believes in the startup's innovative technology and envisions a future where the startups bring out more such necessary tools”.
Dr Megha Sharma, MD Pathologist and Chief Medical Evangelist at Neuranics says, “Our point-of-care CBC analyser represents a significant leap forward in diagnostic convenience and accessibility. By utilising a simple finger-prick capillary blood sample. We have effectively eliminated the need for traditional venipuncture, making blood testing faster, less invasive, and more patient-friendly. This technology empowers healthcare providers to deliver immediate, actionable insights, even in resource-limited settings, ultimately improving patient outcomes especially in Primary healthcare centres for screening and at emergency setups for triage. ”
Praveen Kumar, Co-founder and CEO, Neuranics, says, “We are re-imagining how we approach diagnostics by bringing instant, accurate blood analysis closer to the patient without compromising on the quality. Our technology empowers clinicians with real-time data, transforming care delivery and elevating patient outcomes.